Dec 12 (Reuters) - OncoSec Medical Inc ONCS.O :
* ONCOSEC CEO SENDS LETTER TO FELLOW SHAREHOLDERS
* DANIEL O'CONNOR, CEO OF ONCOSEC MEDICAL SAYS VOTE "FOR"
CGP/SIRTEX DEAL ON WHITE PROXY CARD
* DANIEL O'CONNOR, CEO OF ONCOSEC MEDICAL SAYS BELIEVE
CGP/SIRTEX
DEAL IS ONLY OPTION THAT PROVIDES CAPITAL TO REACH DATA IN
KEYNOTE STUDIES IN 2020
* DANIEL O'CONNOR, CEO OF ONCOSEC MEDICAL SAYS ONLY MEMBER
OF
BOARD THAT DID NOT SUPPORT CGP/SIRTEX DEAL WAS ALPHA'S APPOINTED
DIRECTOR
* DANIEL O'CONNOR OF ONCOSEC MEDICAL -"DEEPLY CONCERNED"
THAT
FUTURE OF CO IS AT RISK IF UNABLE TO OBTAIN SHAREHOLDER APPROVAL
FOR CGP/SIRTEX DEAL
* DANIEL O'CONNOR OF ONCOSEC -ALPHA TO SUPPORT PROPOSAL ONLY
IF
REDUCED PROPOSED INCREASE FROM 29 MILLION ADDITIONAL SHARES TO
10 MILLION ADDITIONAL SHARES
Source text for Eikon: ID:nBw3Jmxf7a
Further company coverage: ONCS.O
((Reuters.Briefs@thomsonreuters.com;))